It is interesting and entertaining to us as biostatisticians that statistical analysis is subject to "fads" where investigators learn a little bit about a new statistical approach and then, as peer reviewers, recommend it be employed to get any paper accepted. The Net Reclassification Index (NRI) 1 very rapidly became extremely popular a couple of years ago; it was just impossible to do a prediction model without the argument of "but did you consider how much information it added to the prediction using NRI." It turns out that now there is growing concern with the measure, 2-4 and the pendulum has swung where it can be a downside to reviewers when used (although these criticisms may not be completely based on an understanding of strengths and limitations of the approach 5,6 ). As novel statistical approaches are developed and disseminated within the medical research community, consideration should always be taken as to whether the statistical methodology matches the research question.
It is interesting and entertaining to us as biostatisticians that statistical analysis is subject to "fads" where investigators learn a little bit about a new statistical approach and then, as peer reviewers, recommend it be employed to get any paper accepted. The Net Reclassification Index (NRI)
1 very rapidly became extremely popular a couple of years ago; it was just impossible to do a prediction model without the argument of "but did you consider how much information it added to the prediction using NRI." It turns out that now there is growing concern with the measure, 2-4 and the pendulum has swung where it can be a downside to reviewers when used (although these criticisms may not be completely based on an understanding of strengths and limitations of the approach 5, 6 ). As novel statistical approaches are developed and disseminated within the medical research community, consideration should always be taken as to whether the statistical methodology matches the research question.
Survival analysis accounting for competing causes is the new kid on the block for popular analysis requested by reviewers. The method is frequently requested to adjust for other diseases that could potentially bias estimates. Perhaps the "hottest" part of the competing risks methodology is the use of "Fine and Gray" methods 7 … a constantly recurring theme from manuscript reviewers. We suggest that many have used this methodology without knowing the underlying statistical and epidemiological nuances, specifically which components are necessary to answer different types of research questions.
We strongly recommend readers study the wonderful tutorial of these techniques by Austin and colleagues (including Fine as senior author) that points out there is not one, but rather two approaches for competing cause analysis: the Fine and Gray methods discussed above, and cause-specific analysis. 8 Additional discussion and illustration with infectious disease focus is provided by Lau et al. 
2.
The other competing cause analysis is the "cause-specific analysis" that tackles a different problem of biased estimated risk coefficients from proportional hazards analysis due to removal of participants/patients by a different disease. In this case those remaining at risk for development of the disease of interest are no longer representative of those at baseline who were initially at risk for developing the disease of interest. Should this happen, the estimates from ordinary proportional hazards analysis result in biased risk estimates. Like the Fine and Gray methods, this becomes a larger concern when other diseases are both common and related to the disease of interest. The cause-specific analysis can be easily implemented by "censoring" (removing participants/patients from being at risk) when they develop the other diseases. Because of its mathematical structure, the cause-specific proportional hazards model is identical to some models ignoring competing risks.
